<p>Patient informed of increased risk of stroke, MI, and other cardiovascular thrombotic events that have been demonstrated to be associated with chronic, long term use of NSAIA agents and COX-2 inuibitors, one of which patient is prescribed.  Patient advised to use the medication for needed analgesic benefit, but to also keep the use to the least frequency needed.</p>